(HYDROXYPROPYL CELLULOSE OPHTHALMIC INSERT)
STERILE OPHTHALMIC INSERT
LACRISERT (hydroxypropyl cellulose ophthalmic insert) is a sterile, translucent, rod-shaped, water soluble, ophthalmic insert made of hydroxypropyl cellulose, for administration into the inferior cul-de-sac of the eye.
LACRISERT is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions.
LACRISERT is also indicated for patients with:
Decreased corneal sensitivity
Recurrent corneal erosions
Published Studies Related to Lacrisert (Hydroxypropyl Cellulose Ophthalmic)
Single instillation of hydroxypropylcellulose-doxorubicin as treatment for superficial bladder carcinoma. 
A single instillation of hydroxypropylcellulose (HPC)-doxorubicin (20 mg/20 ml) was performed in 20 patients with superficial bladder carcinoma. The therapeutic effect was assessed by cystoscopy at 14-30 days after the instillation, and the residual tumor tissue was resected by transurethral resection (TUR) when possible...
Long-term use of hydroxypropyl cellulose ophthalmic insert to relieve symptoms of dry eye in a contact lens wearer: case-based experience. [2011.01]
OBJECTIVES: To report a case in which hydroxypropyl cellulose ophthalmic inserts were successfully used for the treatment of dry eye disease in a contact lens (CLs) wearer for more than 25 years... CONCLUSIONS: Dry eye is a chronic disease often requiring long-term management. In this case, daily use of hydroxypropyl cellulose ophthalmic inserts effectively treated autoimmune dry eye, providing symptomatic relief, and resulted in improved objective measures of disease severity across several decades. Such an experience is consistent with the available evidence-based data for hydroxypropyl cellulose ophthalmic inserts and supports their use in clinical practice for the treatment of moderate-to-severe dry eye disease.
Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry. [2010.12]
PURPOSE: To determine acceptability and efficacy of hydroxypropyl cellulose ophthalmic inserts in patients with dry eye syndrome (DES) and additional comorbidities. DESIGN: A multicenter, 2-visit, open-label, 4-week registry study. PARTICIPANTS: Five hundred twenty patients were recruited to the intent-to-treat group. Four hundred eighteen patients completed the study including 86 contact lens wearers, 79 with cataract diagnosis, 52 with prior cataract surgery, 22 with prior laser-assisted in situ keratomileusis, and 15 with glaucoma... CONCLUSIONS: In subsets of patients with moderate to severe DES and comorbid conditions, hydroxypropyl cellulose ophthalmic inserts improve the symptoms of DES, ability to perform ADLs, and quality of life. The reported benefits may be additive to those seen with patients' existing therapies.
Effect of ethanol on the water permeability of controlled release films composed of ethyl cellulose and hydroxypropyl cellulose. [2010.11]
The robustness of controlled release formulations when co-ingested with alcohol is a current concern expressed by regulatory authorities, especially with regard to dose dumping... The interpretation of the results was supported by dynamic mechanic analysis and SEM analysis.
Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT(R)) therapy with clinical outcomes: tools for predicting response. [2010.10]
BACKGROUND/AIMS: To determine whether patient-reported improvement in symptoms of dry eye syndrome, activities of daily living, and other quality-of-life measures after treatment with hydroxypropyl cellulose ophthalmic inserts correlates significantly with physician assessment of clinical outcomes... CONCLUSIONS: Patient-reported symptoms and activities of daily living are predictors of patient compliance and treatment success with the use of inserts, as reported by treating physicians. The benefits were additive to the standard of care that was continued during the course of the study. These predictors, along with clinical diagnostic tests, can be used by eye care professionals to assess the efficacy of treatment for moderate-to-severe dry eye syndrome quickly and reliably.
Clinical Trials Related to Lacrisert (Hydroxypropyl Cellulose Ophthalmic)
Comparative Efficacy of 20% Benzocaine Versus TAC Alternate Gel [Recruiting]
The project is a study comparing the effectiveness of two topical anesthetics for control of
pain associated with dental needle insertion in the palatal mucosa. A standard dental
topical anesthetic (20% benzocaine) will serve as an "active" control and will be compared
to a combination topical anesthetic, consisting of 20% lidocaine, 4% tetracaine and 2%
phenylephrine (TAC Alternate Gel, Compounding Arts Pharmacy, Lafayette, LA).
Maintenance After Initiation of Nutrition TrAINing [Recruiting]
Obesity is the second leading cause of preventable deaths in the United States and is
associated with a wide range of diseases. In people who are obese, weight loss improves
blood pressure, dyslipidemia, glycemia, and arthritis symptoms; reduces medication use for
several disease processes; increases physical functioning; and enhances health-related
quality of life. The current study will evaluate a theoretically informed maintenance
intervention. If effective, this intervention could reduce the need for future clinic visits
to treat obesity and its many associated illnesses.
Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia [Recruiting]
The purpose of this study is to examine the effect of exendin-(9-39)on glucose requirements
to maintain euglycemia in infants with congenital hyperinsulinism unresponsive to medical
Behavioral Intervention to Maintain Physical Capacity and Activity in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
The purpose of this study is to investigate to what extent patients with COPD, who have
participated in physical training for 12 weeks, can maintain their physical activity
behaviour and physical capacity on a long-term basis if they get a behavioural medicine
Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis [Not yet recruiting]
The relative risk of psoriasis and its severity are directly related to the body mass index
(BMI).Patients with psoriasis likely undergo a vicious circle where obesity and skin disease
reinforce each other. To investigate patients' opinion about their body weight (BW), the
possibility of dietary approach to psoriasis, and to examine the adherence and the effects
of hypo-energetic diet to maintain disease remission in obese patients a dedicated
questionnaire was administered to 200 consecutive patients (125 men and 75 women) with
moderate-to-severe chronic plaque psoriasis investigating whether diet factors could
influence psoriasis severity and course. In second part of study, obese patients with
psoriasis in remission (PASI improvement ≥ 75%) for at least 12 weeks after methotrexate
therapy were randomly assigned to receive a hypo-caloric diet or free diet for 24 weeks, and
then followed up for additional 12 weeks.
Page last updated: 2011-12-09